NMRA
USDNeumora Therapeutics Inc. Common Stock
السعر في الوقت الحقيقي
مخطط الأسعار
المقاييس الرئيسية
مقاييس السوق
الافتتاح
$2.560
الأعلى
$2.920
الأدنى
$2.550
الحجم
1.60M
أساسيات الشركة
القيمة السوقية
480.9M
الصناعة
التكنولوجيا الحيوية
البلد
United States
إحصاءات التداول
متوسط الحجم
1.36M
البورصة
NMS
العملة
USD
نطاق 52 أسبوعاً
أخبار ذات صلة
Neumora Therapeutics to Participate in Upcoming Conferences in November
WATERTOWN, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (NASDAQ:NMRA), a clinical-stage biopharmaceutical company with a therapeutics pipeline consisting of seven programs that target novel
Needham Maintains Buy on Neumora Therapeutics, Raises Price Target to $8
Needham analyst Ami Fadia maintains Neumora Therapeutics with a Buy and raises the price target from $6 to $8.
Guggenheim Upgrades Neumora Therapeutics to Buy, Announces $14 Price Target
Guggenheim analyst Yatin Suneja upgrades Neumora Therapeutics from Neutral to Buy and announces $14 price target.
Neumora Therapeutics Announces Class-Leading Weight Loss Demonstrated with NMRA-215 in Preclinical Diet-Induced Obesity Model
NMRA-215 demonstrated class-leading weight loss of up to 19% as a monotherapy with semaglutide-like induction NMRA-215 demonstrated best-in-class weight loss of up to 26% in combination with semaglutide Class-leading
أسهم ذات صلة
UKOMW
Ucommune International Ltd Warrant expiring 11/17/2025
RRX
Regal Rexnord Corporation
FHTX
Foghorn Therapeutics Inc.
AEF
abrdn Emerging Markets Equity Income Fund Inc.
FFA
First Trust Enhanced Equity Income Fund
ابق على اطلاع
تعيين تنبيهات الأسعار، الحصول على تحديثات تحليل الذكاء الاصطناعي وأخبار السوق في الوقت الحقيقي.